Your browser doesn't support javascript.
loading
Choice of endpoint in kidney outcome trials: considerations from the EMPA-REG OUTCOME® trial.
Perkovic, Vlado; Koitka-Weber, Audrey; Cooper, Mark E; Schernthaner, Guntram; Pfarr, Egon; Woerle, Hans J; von Eynatten, Maximilian; Wanner, Christoph.
Afiliação
  • Perkovic V; The George Institute for Global Health, University of New South Wales, Sydney, Australia.
  • Koitka-Weber A; Boehringer Ingelheim International GmbH, Ingelheim, Germany.
  • Cooper ME; Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia.
  • Schernthaner G; Department of Medicine, Würzburg University Clinic, Würzburg, Germany.
  • Pfarr E; Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia.
  • Woerle HJ; Rudolfstiftung Hospital Vienna, Department of Medicine, Vienna, Austria.
  • von Eynatten M; Boehringer Ingelheim International GmbH, Ingelheim, Germany.
  • Wanner C; Boehringer Ingelheim International GmbH, Ingelheim, Germany.
Nephrol Dial Transplant ; 35(12): 2103-2111, 2020 12 04.
Article em En | MEDLINE | ID: mdl-31495881

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos / Falência Renal Crônica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos / Falência Renal Crônica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article